Biote (BTMD) EBITDA (2021 - 2026)

Biote's EBITDA history runs 6 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, EBITDA rose 84250.0% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at -$8.8 million (up 43.87% YoY), while the FY2025 annual figure was $8.3 million, up 718.66% from the prior year.
• EBITDA was $3.4 million for Q1 2026 at Biote, up from -$20.6 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $68.7 million in Q4 2022 to a low of -$85.3 million in Q2 2022.
• Historically, EBITDA has averaged -$1.1 million across 5 years, with a median of $6000.0 in 2022.
• The sharpest annual moves came in 2022 and 2026: EBITDA tumbled 852980.0% in 2022, then soared 84250.0% in 2026.
• A 5-year view of EBITDA shows it stood at $68.7 million in 2022, then plunged by 91.84% to $5.6 million in 2023, then tumbled by 596.63% to -$27.9 million in 2024, then rose by 25.93% to -$20.6 million in 2025, then soared by 116.32% to $3.4 million in 2026.
• The last three EBITDA figures came in at $3.4 million (Q1 2026), -$20.6 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.